[The treatment of Candida skin diseases with pimaricin].
D000935:Antifungal Agents / Q000627:therapeutic use*; D003883:Arthrodermataceae / Q000187:drug effects; D001446:Balanitis / Q000188:drug therapy; D002175:Candida; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D004357:Drug Synergism; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D003904:Mitosporic Fungi / Q000187:drug effects; D010866:Natamycin / Q000494:pharmacology / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D010304:Paronychia / Q000188:drug therapy; D012882:Skin Tests; D015003:Yeasts / Q000187:drug effects
D000935:Antifungal Agents; D010866:Natamycin; D009355:Neomycin; D006854:Hydrocortisone
Die Behandlung kandidamyzetischer Hautkrankheiten mit Pimaricin.